136 related articles for article (PubMed ID: 15954742)
1. Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits.
Simůnek T; Sterba M; Holecková M; Kaplanová J; Klimtová I; Adamcová M; Gersl V; Hrdina R
Biometals; 2005 Apr; 18(2):163-9. PubMed ID: 15954742
[TBL] [Abstract][Full Text] [Related]
2. Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents.
Simůnek T; Klimtová I; Kaplanová J; Mazurová Y; Adamcová M; Sterba M; Hrdina R; Gersl V
Eur J Heart Fail; 2004 Jun; 6(4):377-87. PubMed ID: 15182761
[TBL] [Abstract][Full Text] [Related]
3. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.
Jirkovský E; Lenčová-Popelová O; Hroch M; Adamcová M; Mazurová Y; Vávrová J; Mičuda S; Šimůnek T; Geršl V; Štěrba M
Toxicology; 2013 Sep; 311(3):191-204. PubMed ID: 23831762
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane.
Lenčová-Popelová O; Jirkovský E; Jansová H; Jirkovská-Vávrová A; Vostatková-Tichotová L; Mazurová Y; Adamcová M; Chládek J; Hroch M; Pokorná Z; Geršl V; Šimůnek T; Štěrba M
J Mol Cell Cardiol; 2016 Feb; 91():92-103. PubMed ID: 26724189
[TBL] [Abstract][Full Text] [Related]
5. Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
Kollárová-Brázdová P; Lenčová-Popelová O; Karabanovich G; Kocúrová-Lengvarská J; Kubeš J; Váňová N; Mazurová Y; Adamcová M; Jirkovská A; Holečková M; Šimůnek T; Štěrbová-Kovaříková P; Roh J; Štěrba M
Clin Sci (Lond); 2021 Aug; 135(15):1897-1914. PubMed ID: 34318878
[TBL] [Abstract][Full Text] [Related]
6. Cardiac troponin T as an indicator of reduced left ventricular contractility in experimental anthracycline-induced cardiomyopathy.
Simůnek T; Klimtová I; Adamcová M; Gersl V; Hrdina R; Sterba M; Kaplanová J; Mazurová Y
Cancer Chemother Pharmacol; 2003 Nov; 52(5):431-4. PubMed ID: 14618274
[TBL] [Abstract][Full Text] [Related]
7. Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death.
Popelová O; Sterba M; Hasková P; Simůnek T; Hroch M; Guncová I; Nachtigal P; Adamcová M; Gersl V; Mazurová Y
Br J Cancer; 2009 Sep; 101(5):792-802. PubMed ID: 19623174
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity.
Sterba M; Popelová O; Simunek T; Mazurová Y; Potácová A; Adamcová M; Kaiserová H; Ponka P; Gersl V
J Pharmacol Exp Ther; 2006 Dec; 319(3):1336-47. PubMed ID: 17003229
[TBL] [Abstract][Full Text] [Related]
9. Effect of sodium 2,3-dimercaptopropane-1-sulphonate (DMPS) on chronic daunorubicin toxicity in rabbits: comparison with dexrazoxane.
Hrdina R; Gersl V; Klimtová I; Simůnek T; Mazurová Y; Machácková J; Adamcová M
Acta Medica (Hradec Kralove); 2002; 45(3):99-105. PubMed ID: 12515046
[TBL] [Abstract][Full Text] [Related]
10. Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
Lenčová-Popelová O; Jansová H; Jirkovský E; Bureš J; Jirkovská-Vávrová A; Mazurová Y; Reimerová P; Vostatková L; Adamcová M; Hroch M; Pokorná Z; Kovaříková P; Šimůnek T; Štěrba M
Toxicology; 2016 Nov; 372():52-63. PubMed ID: 27816693
[TBL] [Abstract][Full Text] [Related]
11. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).
Sterba M; Popelová O; Simůnek T; Mazurová Y; Potácová A; Adamcová M; Guncová I; Kaiserová H; Palicka V; Ponka P; Gersl V
Toxicology; 2007 Jun; 235(3):150-66. PubMed ID: 17459556
[TBL] [Abstract][Full Text] [Related]
12. Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits.
Adamcová M; Potáčová A; Popelová O; Štěrba M; Mazurová Y; Aupperle H; Geršl V
Physiol Res; 2010; 59(5):831-836. PubMed ID: 20406046
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy.
Doka G; Malikova E; Galkova K; La Rocca G; Kruzliak P; Adamek M; Rodrigo L; Krenek P; Klimas J
Mol Cell Biochem; 2017 Aug; 432(1-2):79-89. PubMed ID: 28303410
[TBL] [Abstract][Full Text] [Related]
14. Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat.
Burke BE; Gambliel H; Olson RD; Bauer FK; Cusack BJ
Br J Pharmacol; 2000 Sep; 131(1):1-4. PubMed ID: 10960060
[TBL] [Abstract][Full Text] [Related]
15. Daunorubicin Down-Regulates the Expression of Stem Cell Markers and Factors Involved in Stem Cell Migration and Homing in Rat Heart in Subchronic but not Acute Cardiomyopathy.
Srankova J; Doka G; Pivackova L; Mesarosova L; Kyselovic J; Klimas J; Krenek P
Basic Clin Pharmacol Toxicol; 2016 Nov; 119(5):443-452. PubMed ID: 27090888
[TBL] [Abstract][Full Text] [Related]
16. Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits.
Simůnek T; Klimtová I; Kaplanová J; Sterba M; Mazurová Y; Adamcová M; Hrdina R; Gersl V; Ponka P
Pharmacol Res; 2005 Mar; 51(3):223-31. PubMed ID: 15661572
[TBL] [Abstract][Full Text] [Related]
17. Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value.
Adamcova M; Lencova-Popelova O; Jirkovsky E; Mazurova Y; Palicka V; Simko F; Gersl V; Sterba M
Int J Cardiol; 2015 Dec; 201():358-67. PubMed ID: 26310978
[TBL] [Abstract][Full Text] [Related]
18. Experimental study of dexrazoxane-anthracycline combinations using the model of isolated perfused rat heart.
Plandé J; Platel D; Tariosse L; Robert J
Toxicol Lett; 2006 Feb; 161(1):37-42. PubMed ID: 16129573
[TBL] [Abstract][Full Text] [Related]
19. Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism.
Cusack BJ; Gambliel H; Musser B; Hadjokas N; Shadle SE; Charlier H; Olson RD
Cancer Chemother Pharmacol; 2006 Oct; 58(4):517-26. PubMed ID: 16555089
[TBL] [Abstract][Full Text] [Related]
20. Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits.
Adamcová M; Gersl V; Hrdina R; Melka M; Mazurová Y; Vávrová J; Palicka V; Kokstein Z
J Cancer Res Clin Oncol; 1999; 125(5):268-74. PubMed ID: 10359131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
